Skip to content

We Took A Deep Dive into Cannabis, Marijuana, and CBD — Here’s What We Found

This image depicts a cannabis plant.

LegitScript’s Associate General Counsel, Gerard Olson, takes a deep dive into the regulatory landscape of cannabis, marijuana, and CBD. Read more to understand the regulatory landscape of these products, recent stances the FDA has taken, and what problematic products we’re finding online. Or, watch the full webinar by clicking the button below.

Let’s Define the Difference Between Cannabis, Marijuana, Hemp, and CBD

You’ve heard many terms to describe it — cannabis, marihuana, marijuana and many more. So what’s the difference between the descriptors?

Cannabis is short for Cannabis sativa, Cannabis indica, and Cannabis ruderalis — all three are included in this plant family. Cannabis produces more than 540 chemical substances, and the term is often used to describe all products derived from the plant.

Marijuana is a type of cannabis, and the Drug Enforcement Administration describes it as a mind-altering drug in which the flowers, stems, seeds, and leaves are smoked, vaped, or otherwise ingested for their psychoactive effect. It contains delta-9 tetrahydrocannabinol (THC) — the most well-known chemical derived from cannabis that causes the psychoactive high many associate with the drug.

CBD is one of many cannabinoids found in the cannabis plant that, unlike THC variants, is not generally considered psychoactive. So far, it has been approved for use in an anti-seizure medication but lacks approval for use in supplements and food products.

Lastly, hemp is the fiber or edible seeds from the Cannabis sativa plant that contains low concentrations of THC. It’s safe to manufacture a multitude of products from hemp that compete with more common markets like cotton.

Now that we understand the difference between each, let's dive into the FDA’s stance on cannabis.

 

The FDA’s Stance on Cannabis Products Post-Legalization

In 1996 California became the first state to legalize medicinal marijuana use — and in the years to come most of the country did the same. Currently, there are only four states in the US where marijuana is still illegal.

For CBD, the 2018 Farm Bill opened the door for use in topicals and cosmetics but not food or supplements.

In January of this year, the FDA concluded that existing regulatory frameworks for foods and supplements are not appropriate for cannabidiol. The FDA tasked Congress with discovering “a new way forward.”

In the meantime, the administration has sent a slew of warning letters for products containing CBD that make problematic drug claims and also call out CBD as an unsafe food additive.

 

LegitScript Uncovers Problematic Products Like These

Because cannabis produces so many substances, it’s no surprise some of them lacking explicit regulation are making their way onto the market. The most common of the problematic products sold online is delta-8 THC.

Delta-8 THC is derived from hemp or cannabis. Its chemical compound is similar to delta-9 THC in structure and it’s also psychoactive (though considered less potent). The FDA took a clear stance on delta-8 THC, stating it’s not safe to consume.

🚩 Look out for merchants selling delta-8 THC who claim it is legal to sell everywhere. Many US states have now explicitly banned delta-8 THC.

 

LegitScript regularly identifies products sold online containing potentially problematic cannabinoids such as these:

  • Delta-8 THC
  • Delta-10 THC
  • THC-O-acetate
  • 9-Nor-9β-hydroxyhexahydrocannabinol (HHC)
  • Cannabigerol (CBG)
  • Cannabinol (CBN)
  • Cannabichromene (CBC)
  • Cannabicitran (CBT)
  • Tetrahydrocannabivarin (THCV)
  • Tetrahydrocannabiphorol (THCP)
  • HU-331
  • Cannabidiol-Hydroxy Quinone (CBD HQ)

 

Take A Deep Dive Into Our Webinar Series

Are you curious for more information on the various chemicals cannabis produces, and the products LegitScript uncovers? Click the button below to learn:

  • The history of cannabis products
  • The various chemicals derived from cannabis and hemp
  • The full regulatory landscape of cannabis, marijuana, and CBD

 

Smelting words into subject matter expertise since 2020, Thea Le Fevre specializes in B2B SaaS Content Marketing. She believes in embracing innovation and produces AI-assisted content along with organically crafted content. Take a deep dive into her work for up-to-date industry news surrounding issues in trust & safety, payments risk & compliance, healthcare, and more.

Recent Blog Articles

Addiction Treatment Advisory Committee

Harnessing Collaboration: Highlights from LegitScript’s First Advisory Committee Meeting of the Year

Last year, LegitScript set out to relaunch its Addiction Treatment Certification Advisory Committee in order to strengthen avenues of communication and ensure the continued improvement of its Certification solutions. On March 27, 2024, the revitalized committee convened for the first time. Keep read...

Emerging Threat: Melanotan, Repackaging, and Online Sales

Despite continued regulatory action and potentially dangerous health effects, a social media trend promoting Melanotan II - an illicit tanning drug - continues to prevail in the market. LegitScript has observed that in an attempt to skirt account termination and regulatory scrutiny, merchants common...

Problematic Product Spotlight: Tianeptine

LegitScript has observed a recent rise in both the popularity and regulatory scrutiny of tianeptine, an unregulated substance commonly sold in gas stations and online - and often marketed with unproven claims to be a cognitive enhancer as well as an alternative to opioids. As such, manufacturers hav...
CBD Hemp oil, Hand holding droplet of Cannabis oil against Marijuana buds. Alternative Medicine

What You Need to Know About CBD Product Labeling Regulations

From CBD product labels that claim to diagnose, cure, mitigate, treat, or prevent disease to truth-in-advertising requirements - LegitScript explores the regulatory environment of CBD as it exists today. Then download our CBD Compliance Resource Guide or create an account to apply for your CBD Certi...